Q2 2025
Released Aug 11, 2025, after the close
10-Q filed Aug 11, 2025, 42 days after period end · 0000950170-25-106587
Q2 2025 · 10-Q
Revenue$0.00$0.00 — vs Q2 2024no prior Q1 2025 on file
Net Income-$2.78M-$2.78M N/M vs Q2 2024N/M vs Q1 2025
EPS Diluted-$0.58-$0.58 N/M vs Q2 2024N/M vs Q1 2025
Operating Income-$2,843,000N/M
Operating Cash Flowderived-$1,817,000N/M
What the release said
No earnings release is on file for this quarter. Its figures came with the 10-Q.
Same quarter
| Metric | Q2 2025 | Q2 2024 | Q2 2023 | Q2 2022 |
|---|---|---|---|---|
| Revenue | $0.00 | $0.00 | $0.00 | $0.00 |
| Net Income | -$2.78M | -$4.08M | -$3.39M | -$2.34M |
| EPS Diluted | -$0.58 | -$3.32 | -$7.93 | -$5.77 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Palisade Bio, Inc. · CIK 1357459 · Engraved from SEC EDGAR